Key result
Endovascular repair of thoracic aortic aneurysms did not reduce overall hospital charges compared to open repair, but resulted in zero deaths before discharge.
Why the study?
Endovascular technologies represent major advancements in treating descending thoracic aortic aneurysms, but comparative hospital cost data versus open repair are limited.
Does TEVAR reduce hospital charges compared to OTAR in patients with descending thoracic aortic aneurysms?
Observational (n=100)
Does TEVAR reduce hospital charges compared to OTAR in patients with descending thoracic aortic aneurysms?
Answers are grounded in this paper and cite their sources.
While TEVAR does not significantly reduce overall hospital charges due to high device costs, it offers significant clinical benefits including improved in-hospital mortality and shorter length of stay compared to open repair.
BACKGROUND: Endovascular technologies represent major advancements in treating descending thoracic aortic aneurysms (DTAA). We compared hospital charges of open thoracic aortic replacement (OTAR) with endovascular repair of thoracic aortic aneurysms (TEVAR). METHODS: Retrospective analysis of hospital charges related to repair of DTAA (2000-2009). Charges were inflation adjusted for dollars in 2009. RESULTS: There were 50 OTAR and 50 TEVAR patients. Open thoracic aortic replacement charges were $64 531 (interquartile range [IQR]: 49 000-108 515) versus $61 909 (IQR: 41 307-92 109) for TEVAR(P = .4). A total of 10 patients (10%) died before discharge, with 0 TEVAR deaths (P < .05). For OTAR, supply charges ($9167) accounted for 13% of total charges versus 56% for TEVAR ($40 468), P < .01. Open thoracic aortic replacement length of stay (LOS) was 12 days (6 days intensive care unit [ICU] stay); bed charges comprised 40% of the total charges. Thoracic endovascular aneurysm repair had lower LOS (5days with 2 days ICU stay, P < .001). CONCLUSIONS: Descending thoracic aortic aneurysm repair remains a formidable operation with significant resource utilization. Thoracic endovascular aneurysm repair does not significantly reduce overall hospital charges due to device costs but demonstrates improved mortality, ICU, and total LOS.
No takes yet. Share an insight, caveat, or question.
Arnaoutakis et al. (2010) conducted an observational in Descending thoracic aortic aneurysms (n=100). Endovascular repair of thoracic aortic aneurysms (TEVAR) vs. Open thoracic aortic replacement (OTAR) was evaluated on Hospital charges (p=0.4). Endovascular repair of thoracic aortic aneurysms did not reduce overall hospital charges compared to open repair, but resulted in zero deaths before discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: